O'Day Daniel Patrick 4

What Happened
Daniel Patrick O'Day, Chairman, CEO and Director of Gilead Sciences (GILD), sold 10,000 shares on 2026-03-27. The Form 4 lists an aggregate sale amount of $1,368,162 and a reported per-share amount of $136.82; a footnote clarifies actual sale prices ranged from $136.51 to $137.22. This was a sale (S) reported as an open-market or private sale and executed pursuant to a Rule 10b5-1 trading plan adopted February 28, 2025.

Key Details

• Transaction date: March 27, 2026; Form 4 filed March 30, 2026 (timely filing).
• Reported quantity and value: 10,000 shares sold for an aggregate of $1,368,162; reported per-share $136.82.
• Footnotes: Sale executed under a 10b5-1 plan (adopted 2/28/2025). Report notes sale prices actually ranged $136.51–$137.22 and that a full breakdown is available on request.
• Shares owned after the transaction: not disclosed in the provided filing details.
• Transaction type: S = Sale (open-market/private).

Context
Sales executed under a pre-established 10b5-1 plan are generally scheduled in advance and are less informative about the insider’s near-term view of the company than ad hoc sales. For retail investors, purchases typically carry more informational weight than routine, pre-planned sales; this filing documents a routine, pre-arranged disposition rather than an impromptu trade.